Ribosomal s6 kinase



In molecular biology, ribosomal s6 kinase (rsk) is a family of protein kinases involved in signal transduction. There are two subfmilies of rsk, p90rsk, also known as MAPK-activated protein kinase-1 (MAPKAP-K1), and p70rsk, also known as S6-H1 Kinase. There are three variants of p90rsk in humans, rsk 1-3. Rsks are serine/threonine kinases and are activated by the MAPK/ERK pathway.

Substrates
Rsk is named for ribosomal protein s6, part of the mechanism of translation, but several other substrates have been identified, including other ribosomal proteins. Cytosolic substrates of p90rsk include protein phosphatase 1; glycogen synthase kinase 3 (GSK3); L1 CAM, a neural cell adhesion molecule; Son of Sevenless, the Ras exchance factor; and Myt1, an inhibitor of cdc2.

p90rsk also regulates transcription factors including cAMP response element-binding protein (CREB); estrogen receptor-α (ERα); IκBα/NFκB; and c-Fos.

Genomics
p90 Rsk-1 is located at 1p.

p90 Rsk-2 is located at Xp22.2 and contains 22 exons. Mutations in this gene have been associated with Coffin-Lowry syndrome, a disease characterised by severe psychomotor retardation and other developmental abnormalities.

p90 Rsk-3 is located at 6q27.

Proteomics
The main distinguishing feature between p90rsk and p70rsk is that the 90 kDa family contain two non-identical kinase domains, while the 70 kDa family contain only one kinase domain.

Research history
Rsk was first identified in Xenopus laevis eggs by Erikson and Maller in 1985.